Page 2 - Peter Hecht News Today

(Bloomberg) -- Colm Kelleher whipped up a storm at the end of last year when the UBS Group AG chairman warned of a dangerous bubble in private credit. As investors dive headfirst into this booming asset class, the more urgent question for regulators is how anybody could even know for sure what it’s really worth.Most Read from BloombergApple to Wind Down Electric Car Effort After Decadelong OdysseyA Spike in Heart Disease Deaths Since Covid Is Puzzling ScientistsOffice Tower Deal for $1 Re...

Fund managers in this red-hot asset class are often valuing their loans more generously than others do. Regulators are starting to worry.

The Editors on “The Wisdom of our Ancestors,” Master Drawings New York, Dutch art, Mahler & more

SOUTHBURY — The Inland Wetlands Commission agreed to lift a cease-and-desist action against Peter and Thomas Hecht, as owners of 179, 18, and 177 West Flat Hill Rd., during a

SOUTHBURY — Inland Wetlands commissioners held a show cause hearing Tuesday, September 26, on violations at 179 West Flat Hill Rd., owned by Peter Hecht, and 181 West Flat Hill

A Phase 2b-ready Cyclerion Therapeutics drug candidate for a rare mitochondrial disease gets new life under a new startup led by a familiar face. Starup Tisento Therapeutics acquired the Cyclerion drug and is backed by a Series A round financing.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Following the transaction, the new company will be responsible for developing and commercializing zagociguat and CY3018.

BioPharma

Investors should not count on a return to the negative SBC relationship of the past 25 years.